Bill > S1862

This bill aims to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing. It proposes to amend Massachusetts' tax law by disallowing the deduction described in Section 162(a) of the Internal Revenue Code, which allows businesses to deduct ordinary and necessary expenses, to the extent that this deduction applies to direct consumer advertising of prescription drugs. This includes all direct and indirect costs related to advertising prescription drugs and devices to patients in Massachusetts, such as media advertising, coupons, outreach programs, and other forms of marketing. The disallowed amount for national or regional programs would be the proportionate share of expenses directed to Massachusetts residents.

Budget and Finance

https://malegislature.gov/Bills/193/S1862